Chemo-Pharma Laboratories Ltd. is significantly underperforming compared to its peers in terms of profitability and growth metrics. The analysis reveals strong competitors like Sun Pharmaceutical Industries and Dr. Reddy's Laboratories, indicating a challenging market position for the target company. Chemo-Pharma is burdened with negative returns and no revenue growth, making it financially weak amid a robust sector.

• • Chemo-Pharma exhibits negative EPS and ROE, indicating severe financial distress.
• • Top performers like Sun Pharma and Dr. Reddy's boast solid growth and profitability metrics.
• • Valuation metrics of Chemo-Pharma suggest it is overvalued compared to its peers, lacking growth prospects.